Peptide Drug Discovery Market Size, Revenue, Forecast Report 2026 to 2035
Segmentation of Peptide Drug Discovery Market -
Peptide Drug Discovery Market by Type of Product -
- Synthetic peptides
- Biological peptides
- Recombinant peptides
- Macrocycles peptides
Peptide Drug Discovery Market by Drug Discovery Steps -
- Target Identification and Validation
- Hit Identification
- Lead Generation
- Lead Optimization
Peptide Drug Discovery Market by Therapeutic Area -
- Oncological disorders
- Metabolic disorders
- Cardiovascular disorders
- Infectious disorders
- Urological disorders
- Endocrine disorders
- CNS disorders
- Other diseases
Peptide Drug Discovery Market by Company Size -
- Small
- Mid-sized
- Large and very large
Peptide Drug Discovery Market by Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Peptide Drug Discovery Market Snapshot
Chapter 4. Global Peptide Drug Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Product Estimates & Trend Analysis
5.1. by Type of Product & Market Share, 2025 & 2035
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Type of Product:
5.2.1. Synthetic Peptides
5.2.2. Biological Peptides
5.2.3. Recombinant Peptides
5.2.4. Macrocycles Peptides
Chapter 6. Market Segmentation 2: by Drug Discovery Steps Estimates & Trend Analysis
6.1. by Drug Discovery Steps & Market Share, 2025 & 2035
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Drug Discovery Steps:
6.2.1. Target Identification and Validation
6.2.2. Hit Identification
6.2.3. Lead Generation
6.2.4. Lead Optimization
Chapter 7. Market Segmentation 3: by Therapeutic Area Estimates & Trend Analysis
7.1. by Therapeutic Area & Market Share, 2025 & 2035
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Therapeutic Area:
7.2.1. Oncological disorders
7.2.2. Metabolic disorders
7.2.3. Cardiology Surgery
7.2.4. Neurology
7.2.5. Cardiovascular disorders
7.2.6. Infectious disorders
7.2.7. Urological disorders
7.2.8. Endocrine disorders
7.2.9. CNS disorders
7.2.10. Other diseases
Chapter 8. Market Segmentation 4: by Company Size Estimates & Trend Analysis
8.1. by Company Size & Market Share, 2025 & 2035
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Company Size:
8.2.1. Small
8.2.2. Mid-Sized
8.2.3. Large and very large
Chapter 9. Peptide Drug Discovery Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035
9.1.2. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035
9.1.3. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035
9.1.4. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035
9.1.5. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035
9.2. Europe
9.2.1. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035
9.2.2. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035
9.2.3. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035
9.2.4. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035
9.2.5. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035
9.3. Asia Pacific
9.3.1. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035
9.3.2. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035
9.3.3. Asia-Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035
9.3.4. Asia-Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035
9.3.5. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035
9.4. Latin America
9.4.1. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035
9.4.2. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035
9.4.3. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035
9.4.4. Latin Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035
9.4.5. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035
9.5. Middle East & Africa
9.5.1. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035
9.5.2. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035
9.5.3. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035
9.5.4. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035
9.5.5. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. GenScript
10.2.2. JPT Peptide Technologies
10.2.3. CPC Scientific
10.2.4. IRBM
10.2.5. Creative Peptides
10.2.6. Pepscan
10.2.7. Peptides and Macrocycle Drug Discovery Platform Providers
10.2.8. RA Pharmaceuticals
10.2.9. Pepticom
10.2.10. PeptiDream
10.2.11. Creative Biolabs
10.2.12. MeSCue-Janusys
10.2.13. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Peptide Drug Discovery Market Size is valued at 810.85 Mn in 2025 and is predicted to reach 2,481.57 Mn by the year 2035.
Peptide Drug Discovery Market is predicted to develop at an 12.2% CAGR during the forecast period for 2026-2035.
CPC Scientific, IRBM, Creative Peptides, Pepscan, Peptides and Macrocycle Drug Discovery Platform, Providers, RA Pharmaceuticals, Pepticom, PeptiDream
Peptide drug discovery market is type of product, type of drug discovery steps, type of therapeutic area, and company size.
North American region is leading the Peptide drug discovery market.